男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)

Multiplex Assay Kit for Suppressors Of Cytokine Signaling 3 (SOCS3) ,etc. by FLIA (Flow Luminescence Immunoassay)

ATOD4; CIS3; Cish3; MGC71791; SOCS-3; SSI-3; SSI3; Cytokine-inducible SH2 protein 3; STAT-induced STAT inhibitor 3

(注:單次混測多因子不超過8個指標 )

  • 細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)產(chǎn)品包裝(模擬)
  • 細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)產(chǎn)品包裝(模擬)
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

本試劑盒用于檢測細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應。

回收率

分別于定值血清及血漿樣本中加入一定量的細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)(加標樣品),重復測定并計算其均值,回收率為測定值與理論值的比率。

樣本回收率范圍(%)平均回收率(%)
serum(n=5)80-8981
EDTA plasma(n=5)84-9489
heparin plasma(n=5)80-10189

精密度

精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復測定8次,分別計算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%

線性

在定值血清及血漿樣本內(nèi)加入適量的細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)含量的測定值與理論值的比率。

樣本1:21:41:81:16
serum(n=5)96-103%86-94%97-104%86-94%
EDTA plasma(n=5)82-102%87-95%91-98%89-101%
heparin plasma(n=5)98-105%91-99%91-101%98-105%

穩(wěn)定性

經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內(nèi)溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。

實驗流程

1. 實驗前標準品、試劑及樣本準備;
2. 加樣(標準品、樣本、磁珠)標準品或樣本100μL及磁珠10μL,
    37°C酶標板振蕩器孵育90分鐘;
3. 磁吸甩干,加檢測溶液A100μL,37°C酶標板振蕩器孵育60分鐘;
4. 磁吸洗板3次;
5. 加檢測溶液B100μL,37°C振動孵育30分鐘;
6. 磁吸洗板3次;
7. 加鞘液100μL,旋渦震蕩2分鐘后讀數(shù)。

實驗原理

將細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)抗體包被于磁珠,制成固相載體,向微孔中分別加入標準品或標本以及磁珠,其中的細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)抗體,將未結(jié)合的生物素化抗體洗凈后,加入PE標記的親和素,再次徹底洗滌后即可上機讀數(shù)。MFI值和樣品中的細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)呈正相關(guān)。

贈品

相關(guān)產(chǎn)品

編號適用物種:Mus musculus (Mouse,小鼠)應用(僅供研究使用,不用于臨床診斷!)
RPB684Mu02細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPB684Mu01細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APB684Mu01細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)活性蛋白Cell?culture;?Activity?Assays.
PAB684Mu02細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)多克隆抗體WB; IHC; ICC; IP.
PAB684Mu01細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)多克隆抗體WB; IHC; ICC; IP.
LAB684Mu71細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)多克隆抗體(生物素標記)WB; IHC; ICC.
LAB684Mu81細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)多克隆抗體(異硫氰酸熒光素標記)WB; IHC; ICC; IF.
SEB684Mu細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMB684Mu細胞因子信號轉(zhuǎn)導抑制因子3(SOCS3)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻

雜志參考文獻
The Journal of Biological ChemistryHuman primary keratinocytes show a restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 compared to autologous macrophages[Jcb: 280370]
The Journal of Biological ChemistryHuman Primary Keratinocytes Show Restricted Ability to Up-regulate Suppressor of Cytokine Signaling (SOCS)3 Protein Compared with Autologous Macrophages[PubMed: PMC3323061]
Journal of Reproductive ImmunologyWhat is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility?[Pubmed: 24368037]
The Journal of ImmunologyAlveolar Epithelial Cell–Derived Prostaglandin E2?Serves as a Request Signal for Macrophage Secretion of Suppressor of Cytokine Signaling 3 during Innate Inflammation[Pubmed:27183597]
Scientific ReportsThe FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway[pubmed:28970500]
Journal of Immunological MethodsEndogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs.[pubmed:29154772]
Turkish?Journal Of?Medical?SciencesThe impact of plasma SOCS3 levels and endometrial leukocytes on unexplained infertility[Pubmed:29914245]
Novel trajectories of Bromocriptine antidiabetic action: Leptin-IL-6/JAK2/p-STAT3/SOCS3, p-IR/p-AKT/GLUT4, PPARγ/Adiponectin, Nrf2/PARP-1, and GLP-1[articles:10.3389]
JCI InsightAlveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeutics[Pubmed: 31619584]
European Journal of PharmacologyOlmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways[Pubmed: 32067934]
FASEB JOURNALResident alveolar macrophage‐derived vesicular SOCS3 dampens allergic airway inflammation[Pubmed: 32030817]
molecular immunologySOCS3-deficient lung epithelial cells uptaking neutrophil-derived SOCS3 worsens lung influenza infection[Pubmed: 32645550]
Experimental and Therapeutic MedicineChanges and clinical significance of serum inflammatory factors in the treatment of pregnancy hypertension syndrome with magnesium sulfate combined with …[Pubmed: 32742411]
NEUROCHEMICAL RESEARCHModulation of the Nitric Oxide/BH4 Pathway Protects Against Irradiation-Induced Neuronal Damage[33755856]
BIOMEDICINE & PHARMACOTHERAPYPotential contribution of ELISA and LFI Assays to assessment of the oxidative stress condition based on 8-oxodG biomarker[33957564]